Ethical considerations of the genetic testing for patients with cardiovascular disease
Keywords:
Genetic Testing, cardiovascular disease, ethical considerationsAbstract
Findings of genetic markers for cardiovascular diseases (CVDs) have aided in the development of genetic tests and drug discovery and development strategies. Studies on cardiovascular genetics have reported several genetic variants associated with the risk of heart disease. Studies have shown that most disease-causing genetic variants are unique familial ones, suggesting the need to include genetic counselling for affected individuals. However, many ethical issues arise in genetic testing. Using personal genetic information is addressed within the framework of protecting patient autonomy. This review will discuss the ethical considerations of genetic testing for cardiovascular diseases.
Downloads
References
Akkaif, M A, A Sha'aban, N A A Daud, D A M Noor, N F Musa, M A Sk Abdul Kader, and B Ibrahim. 2022. 'Fast and more affordable CYP2C19 LOF testing to personalized of clopidogrel therapy', European heart journal, 43.
Akkaif, Mohammed Ahmed, Ahmad Naoras Bitar, Laith AIK Al-Kaif, Nur Aizati Athirah Daud, Abubakar Sha’aban, Dzul Azri Mohamed Noor, Fatimatuzzahra’ Abd Aziz, Arturo Cesaro, Muhamad Ali SK Abdul Kader, and Mohamed Jahangir Abdul Wahab. 2022. 'The management of myocardial injury related to SARS-CoV-2 pneumonia', Journal of Cardiovascular Development and Disease, 9: 307.
Akkaif, Mohammed Ahmed, Nur Aizati Athirah Daud, Abubakar Sha’aban, Mei Li Ng, Muhamad Ali Sk Abdul Kader, Dzul Azri Mohamed Noor, and Baharudin Ibrahim. 2021. 'The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)', Molecules, 26: 1987.
Akkaif, Mohammed Ahmed, Mei Li Ng, Muhamad Ali SK Abdul Kader, Nur Aizati Athirah Daud, Abubakar Sha’aban, and Baharudin Ibrahim. 2021. 'A review of the effects of ticagrelor on adenosine concentration and its clinical significance', Pharmacological Reports: 1-14.
Akkaif, Mohammed Ahmed, Abubakar Sha’aban, Arturo Cesaro, Ammar Ali Saleh Jaber, Andrea Vergara, Ismaeel Yunusa, Abubakar Ibrahim Jatau, Mustapha Mohammed, G Saravana Govindasamy, and Majed Ahmed Al-Mansoub. 2022. 'The impact of SARS-CoV-2 treatment on the cardiovascular system: An updated review', Inflammopharmacology: 1-9.
Akkaif, Mohammed Ahmed, Abubakar Sha’aban, Nur Aizati Athirah Daud, Mei Li Ng, and Baharudin Ibrahim. 2020. 'Investigate the Strategy of Using Pharmacogenetics and Pharmacometabonomics to the Personalization of Ticagrelor Antiplatelet Therapy', Syst. Rev. Pharm, 11: 1100-07.
Akkaif, Mohammed Ahmed, Abubakar Sha’aban, Nur Aizati Athirah Daud, Ismaeel Yunusa, Mei Li Ng, Muhamad Ali SK Abdul Kader, Dzul Azri Mohamed Noor, and Baharudin Ibrahim. 2021. 'Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Journal of Cardiovascular Development and Disease, 8: 123.
Al-Kaif, Laith AIK, Alaa H Al-Charrakh, and Mohammad AK Al-Saadi. 2022. 'Frequency distribution of hepatitis B virus (HBV) genotypes in Iraqi patients'.
Al-Kaif, Laith AIK, Mohammad AK Al-Saadi, and Alaa H Al-Charrakh. 2022. 'Coinfection of COVID-19 and viral hepatitis: A Rapid Review'.
Andorno, Roberto. 2004. 'The right not to know: an autonomy based approach', Journal of Medical Ethics, 30: 435-39.
Andrews, L, J Fullarton, NA Holtzman, and AG Motulsky. 1994. 'Social, legal, and ethical implications of genetic testing.' in, Assessing Genetic Risks: Implications for health and social policy (National Academy Press, Washington, DC).
Bell, Damon A, Jing Pang, Sally Burrows, Timothy R Bates, Frank M van Bockxmeer, Amanda J Hooper, Peter O'Leary, John R Burnett, and Gerald F Watts. 2015. 'Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience', Atherosclerosis, 239: 93-100.
Bitar, Ahmad N, Muhammad Ali Ghoto, Abdullah Dayo, Mudassar Iqbal Arain, and Rabia Parveen. 2017. 'Pathophysiological correlation between diabetes mellitus type-II & chronic obstructive pulmonary diseases', J Liaquat Uni Med Health Sci, 16: 41-8.
Bitar, Ahmad Naoras, Syed Azhar Syed Sulaiman, Irfhan Ali Bin Hyder Ali, and Amer Hayat Khan. 2021. 'Prevalence, risk assessment, and predictors of osteoporosis among chronic obstructive pulmonary disease patients', Journal of advanced pharmaceutical technology & research, 12: 395.
Cassa, Christopher A, Mark Y Tong, and Daniel M Jordan. 2013. 'Large numbers of genetic variants considered to be pathogenic are common in asymptomatic individuals', Human mutation, 34: 1216-20.
Chinn, Ivan K, Alice Y Chan, Karin Chen, Janet Chou, Morna J Dorsey, Joud Hajjar, Artemio M Jongco III, Michael D Keller, Lisa J Kobrynski, and Attila Kumanovics. 2020. 'Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: a working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology', Journal of Allergy and Clinical Immunology, 145: 46-69.
Christensen, Kurt D, Dmitry Dukhovny, Uwe Siebert, and Robert C Green. 2015. 'Assessing the costs and cost-effectiveness of genomic sequencing', Journal of personalized medicine, 5: 470-86.
Clarke, Angus J, and Carina Wallgren-Pettersson. 2019. 'Ethics in genetic counselling', Journal of Community Genetics, 10: 3-33.
Counselors, National Society of Genetic. 2006. '’Definition Task Force, Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, et al. A new definition of genetic counseling: national society of genetic counselors’ task force report', J Genet Couns, 15: 77-83.
Cowan, Jason, Ana Morales, Jimena Dagua, and Ray E Hershberger. 2008. 'Genetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations', Congestive Heart Failure, 14: 97-105.
Fulda, Kimberly G, and Kristine Lykens. 2006. 'Ethical issues in predictive genetic testing: a public health perspective', Journal of Medical Ethics, 32: 143-47.
Gollob, Michael H, Louis Blier, Ramon Brugada, Jean Champagne, Vijay Chauhan, Sean Connors, Martin Gardner, Martin S Green, Robert Gow, and Robert Hamilton. 2011. 'Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper', Canadian Journal of Cardiology, 27: 232-45.
Grosse, Scott D, Lisa Kalman, and Muin J Khoury. 2010. 'Evaluation of the validity and utility of genetic testing for rare diseases', Rare Diseases Epidemiology: 115-31.
Hannah-Shmouni, Fady, Sara B Seidelmann, Sandra Sirrs, Arya Mani, and Daniel Jacoby. 2015. 'The genetic challenges and opportunities in advanced heart failure', Canadian Journal of Cardiology, 31: 1338-50.
Ingles, Jodie, Charlotte Burns, Alexandra Barratt, and Christopher Semsarian. 2015. 'Application of genetic testing in hypertrophic cardiomyopathy for preclinical disease detection', Circulation: Cardiovascular Genetics, 8: 852-59.
Ingles, Jodie, Ivan Macciocca, Ana Morales, and Kate Thomson. 2020. 'Genetic testing in inherited heart diseases', Heart, Lung and Circulation, 29: 505-11.
Ingles, Jodie, and Christopher Semsarian. 2014. 'The value of cardiac genetic testing', Trends in Cardiovascular Medicine, 24: 217-24.
Leenen, Celine HM, Mariska den Heijer, Conny van der Meer, Ernst J Kuipers, Monique E van Leerdam, and Anja Wagner. 2016. 'Genetic testing for Lynch syndrome: family communication and motivation', Familial Cancer, 15: 63-73.
Louter, Leonora, Joep Defesche, and Jeanine Roeters van Lennep. 2017. 'Cascade screening for familial hypercholesterolemia: practical consequences', Atherosclerosis supplements, 30: 77-85.
Menko, Fred H, Cora M Aalfs, Lidewij Henneman, Yrrah Stol, Miranda Wijdenes, Ellen Otten, Marleen MJ Ploegmakers, Johan Legemaate, Ellen Smets, and Guido MWR de Wert. 2013. 'Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists', Familial Cancer, 12: 319-24.
Mills, Rachel A, Susanne B Haga, and Geoffrey S Ginsburg. 2012. 'Genetic testing: clinical and personal utility', AMA Journal of Ethics, 14: 604-09.
Mital, Seema, Kiran Musunuru, Vidu Garg, Mark W Russell, David E Lanfear, Rajat M Gupta, Kathleen T Hickey, Michael J Ackerman, Marco V Perez, and Dan M Roden. 2016. 'Enhancing literacy in cardiovascular genetics: a scientific statement from the American Heart Association', Circulation: Cardiovascular Genetics, 9: 448-67.
Musunuru, Kiran, Ray E Hershberger, Sharlene M Day, N Jennifer Klinedinst, Andrew P Landstrom, Victoria N Parikh, Siddharth Prakash, Christopher Semsarian, Amy C Sturm, American Heart Association Council on Genomic, Precision Medicine, Thrombosis Council on Arteriosclerosis, Vascular Biology, Council on Cardiovascular, Stroke Nursing, and Council on Clinical Cardiology. 2020. 'Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association', Circulation: Genomic and Precision Medicine, 13: e000067.
Pinxten, Wim, and Heidi Carmen Howard. 2014. 'Ethical issues raised by whole genome sequencing', Best Practice & Research Clinical Gastroenterology, 28: 269-79.
Richards, Sue, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, and Elaine Spector. 2015. 'Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology', Genetics in Medicine, 17: 405-23.
Schneider, Katherine, Kristin Zelley, Kim E Nichols, and Judy Garber. 2019. 'Li-fraumeni syndrome'.
Schuurman, Agnes G, Dorina M Van Der Kolk, Marian A Verkerk, Erwin Birnie, Adelita V Ranchor, Mirjam Plantinga, and Irene M Van Langen. 2015. 'Maximising the efficiency of clinical screening programmes: balancing predictive genetic testing with a right not to know', European Journal of Human Genetics, 23: 1124-28.
Tardiff, Jil C, Lucie Carrier, Donald M Bers, Corrado Poggesi, Cecilia Ferrantini, Raffaele Coppini, Lars S Maier, Houman Ashrafian, Sabine Huke, and Jolanda Van Der Velden. 2015. 'Targets for therapy in sarcomeric cardiomyopathies', Cardiovascular Research, 105: 457-70.
van Velzen, Hannah G, Arend FL Schinkel, Sara J Baart, Rogier A Oldenburg, Ingrid ME Frohn-Mulder, Marjon A van Slegtenhorst, and Michelle Michels. 2018. 'Outcomes of contemporary family screening in hypertrophic cardiomyopathy', Circulation: Genomic and Precision Medicine, 11: e001896.
Zawiah, Mohammed, Al-Motassem Yousef, Fahmi Y Al-Ashwal, Rami Abduljabbar, Sayida Al-Jamei, Amer Hayat Khan, and Batool Alkhawaldeh. 2021. 'Pharmacogenetics: A perspective and preparedness of Pharm-D and medical students in Jordan', Pharmacogenetics and genomics, 31: 125-32.
Zawiah, Mohammed, Al-Motassem Yousef, Taha Kadi, Mohammed Yousef, Khalil Majdalawi, Shorouq Al-Yacoub, Rasha Al-Hiary, Dua’a Tantawi, Ramzi Mukred, and Abdel Rahman Ajaj. 2018. 'Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy', Drug metabolism and personalized therapy, 33: 201-05.
Published
Issue
Section
License
Copyright (c) 2024 Malaysian Journal of Human Genetics
This work is licensed under a Creative Commons Attribution 4.0 International License.
